Acrotech Biopharma to Enhance US Presence with Spectrum Pharmaceuticals
By Michelle Liu
Pharma Deals Review: Vol 2019 Issue 1 (Table of Contents)
Published: 30 Jan-2019
DOI: 10.3833/pdr.v2019.i1.2398 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Moving away from niche markets, Spectrum Pharmaceuticals has agreed to sell seven FDA-approved haematology and oncology assets to Acrotech Biopharma, a subsidiary of Aurobindo Pharma...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS